# Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects

> **NCT01489774** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 86 (actual)

## Conditions studied

- Digestive System Diseases

## Interventions

- **DRUG:** Placebo
- **DRUG:** CJ-12406

## Key facts

- **NCT ID:** NCT01489774
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-04
- **Final completion:** 2012-06
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489774, "Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01489774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*